More Business Wire
View Older Stories View Newer Stories-
Samsung Bioepis Releases Fourth Quarter 2025 US Biosimilar Market Report Providing Annual Biosimilar Trends and Future Market Trajectory
-
SymphonyAI Expands Industrial AI Platform With IRIS Forge—AI-Powered Application Creation for Industrial Market
-
Bidgely Introduces UtilityAI Pro, Giving Utility CIOs the First Vertical AI Platform that Transforms Data into Strategic Insights
-
Universal Electronics Inc. to Host Third Quarter 2025 Financial Results Conference Call on November 6th
-
Insulet Announces Appointment of Robert L. Huffines to its Board of Directors
-
Old Dominion Freight Line Announces $0.28 Per Share Quarterly Cash Dividend
-
Bidgely Introduces UtilityAI Pro, Giving Global Utilities and Energy Providers the First Vertical AI Platform that Transforms Data into Strategic Insights
-
All State Fastener Names Dan Hill CEO, Adds Top Industry Talent to Leadership Team to Drive Modernization and Global Growth
-
Rockwell Automation to Report Fourth Quarter Fiscal 2025 Results
-
SymphonyAI Launches Sensa Risk Intelligence to Modernize Financial Compliance with Proven AI Expertise
-
Accelsius Brings Advanced AI Cooling Technology to NVIDIA GTC Washington, D.C.
-
TelevisaUnivision Announces Third Quarter 2025 Results
-
D-Wave Quantum to Report Third Quarter Fiscal Year 2025 Financial Results on November 6, 2025
-
Naobios and Tokyo Metropolitan Institute of Medical Science Partner to Develop New Live-attenuated Vaccine Against mpox
-
BTG Pactual Timberland Investment Group and Tacoma Public Utilities Announce 579-Acre Conservation Deal in Green River Watershed
-
Ranpak to Hold Conference Call to Discuss Third Quarter 2025 Results
-
OBIO® Introduces the Future Female Leaders in Life Sciences
-
Expro Group Holdings N.V. Announces Third Quarter 2025 Results and Increases Full-Year Guidance on Adjusted EBITDA and Adjusted Free Cash Flow
-
T-Mobile Delivers Record Customer Growth, Fueled By Widening Differentiation and Focus on Durable and Profitable Financial Growth, Raises Guidance Across the Board
-
Ryder Reports Third Quarter 2025 Results
-
CBRE Group, Inc. Reports Financial Results for Third-Quarter 2025
-
Tractor Supply Company Reports Third Quarter 2025 Financial Results; Narrows Fiscal Year 2025 Guidance Range
-
Ryder Authorizes New Discretionary and Anti-Dilutive Plans to Repurchase Shares
-
Funko to Host 2025 Third Quarter Financial Results Conference Call on Thursday, November 6, 2025
-
Atmus Filtration Technologies to Announce Third Quarter 2025 Results on November 7, 2025
-
Sonic Automotive Reports Third Quarter 2025 Financial Results
-
Atlantic Union Bankshares Reports Third Quarter Financial Results
-
TechnipFMC Announces Third-Quarter 2025 Results
-
Lindsay Corporation Reports Fourth Quarter and Fiscal Year 2025 Results
-
Ketjen, Axens Reach New Eurecat Relationship and Collaboration Agreements
-
Merck to Present New Data from Its Innovative Cardio-Pulmonary Pipeline and Portfolio at AHA Scientific Sessions 2025
-
Taking Care of Families: BJ’s Wholesale Club Donates Over $1.2 Million to Local Communities
-
Darling Ingredients Inc. Reports Third Quarter 2025 Results
-
Valero Energy Reports Third Quarter 2025 Results
-
Hasbro Reports Third Quarter 2025 Financial Results
-
Lazard Reports Third Quarter and Nine Month 2025 Results
-
Textron Reports Third Quarter 2025 Results
-
Ingevity names Ruth Castillo as senior vice president and president of Performance Materials
-
Swander Pace Capital Selects New CEO to Lead Maple Donuts, LLC, Signaling Strategic Growth Phase for Premium Frozen Bakery Manufacturer
-
Amalgamated Financial Corp. Reports Third Quarter 2025 Financial Results; Rock Solid Balance Sheet; Margin Expands to 3.60%
-
CenterPoint Energy reports strong Q3 2025 results; reiterates 2025 and 2026 full year guidance
-
Ermenegildo Zegna Group Revenues¹ Reach €1.33B in the First Nine Months of 2025; Acceleration in Q3 Driven by Robust DTC Growth Across All Brands
-
TriCo Bancshares Reports Third Quarter 2025 Net Income of $34.0 Million, Diluted EPS of $1.04
-
FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each in Combination with Padcev® (enfortumab vedotin-ejfv), for Certain
-
Allegion (NYSE: ALLE) Reports Q3-2025 Financial Results
-
Consumers Unknowingly Expose Passwords in Password Manager/VPN Exchanges, Feeding The Dark Web: New Research from PureVPN
-
Rockwell Medical Named Fortune 'Best Workplaces in Manufacturing & Production' Second Year in a Row
-
American Strategic Investment Co. Announces Release Date for Third Quarter Results
-
Phoenix Tailings Opens Cutting-Edge U.S. Rare Earth Metallization Facility Entirely Independent From China
-
Economic Headwinds Erode Small Business Satisfaction with Banks in Canada, J.D. Power Finds

